Middle East and Africa Diabetes Devices Market - 2024-2031
Middle East and Africa Diabetes Devices Market reached US$ 1.44 billion in 2023 and is expected to reach US$ 2.77 billion by 2031, growing with a CAGR of 8.70% during the forecast period 2026-2031.
The Middle East and Africa Diabetes Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Middle East and Africa Diabetes Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Device Type
Both primary and secondary data sources have been used in the global Middle East and Africa Diabetes Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Middle East and Africa Diabetes Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Middle East and Africa Diabetes Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Device Type
- Blood Glucose Monitoring (BGM) Devices*
- Self-Monitoring Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Durables
- Others
- Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
- Jet Injectors
- Others
- Others
- Hospital Pharmacies*
- Retail Pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
- Others
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Middle East and Africa Diabetes Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Device Type
3.2. Snippet by Distribution Channel
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing awareness among individuals
4.1.2. Restraints
4.1.2.1. High costs associated with diabetes devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY DEVICE TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
6.1.2. Market Attractiveness Index, By Device Type
6.2. Blood Glucose Monitoring (BGM) Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Self-Monitoring Devices
6.2.3.1. Blood Glucose Meters
6.2.3.2. Testing Strips
6.2.3.3. Lancets
6.2.4. Continuous Glucose Monitoring Devices
6.2.4.1. Sensors
6.2.4.2. Durables
6.2.4.3. Others
6.3. Insulin Delivery Devices
6.3.1. Insulin Pumps
6.3.2. Insulin Pens
6.3.3. Insulin Syringes
6.3.4. Jet Injectors
6.3.5. Others
6.4. Others
7. BY DISTRIBUTION CHANNEL
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
7.1.2. Market Attractiveness Index, By Distribution Channel
7.2. Hospital Pharmacies*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacies
7.4. Diabetes Clinics/Centers
7.5. Online Pharmacies
7.6. Others
8. COMPETITIVE LANDSCAPE
8.1. Competitive Scenario
8.2. Market Positioning/Share Analysis
8.3. Mergers and Acquisitions Analysis
9. COMPANY PROFILES
9.1. Hoffmann-La Roche AG*
9.1.1. Company Overview
9.1.2. Product Portfolio and Description
9.1.3. Financial Overview
9.1.4. Key Developments
9.2. Medtronic Plc
9.3. Abbott Laboratories
9.4. Novo Nordisk A/S
9.5. DexCom, Inc.
9.6. Nipro Medical
9.7. Sol-Millennium Medical Group
9.8. SABIC
9.9. Colexa Biosensor Ltd.
9.10. AMETEK.Inc. (*LIST NOT EXHAUSTIVE)
10. APPENDIX
10.1. About Us and Services
10.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Device Type
3.2. Snippet by Distribution Channel
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing awareness among individuals
4.1.2. Restraints
4.1.2.1. High costs associated with diabetes devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY DEVICE TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
6.1.2. Market Attractiveness Index, By Device Type
6.2. Blood Glucose Monitoring (BGM) Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Self-Monitoring Devices
6.2.3.1. Blood Glucose Meters
6.2.3.2. Testing Strips
6.2.3.3. Lancets
6.2.4. Continuous Glucose Monitoring Devices
6.2.4.1. Sensors
6.2.4.2. Durables
6.2.4.3. Others
6.3. Insulin Delivery Devices
6.3.1. Insulin Pumps
6.3.2. Insulin Pens
6.3.3. Insulin Syringes
6.3.4. Jet Injectors
6.3.5. Others
6.4. Others
7. BY DISTRIBUTION CHANNEL
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
7.1.2. Market Attractiveness Index, By Distribution Channel
7.2. Hospital Pharmacies*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacies
7.4. Diabetes Clinics/Centers
7.5. Online Pharmacies
7.6. Others
8. COMPETITIVE LANDSCAPE
8.1. Competitive Scenario
8.2. Market Positioning/Share Analysis
8.3. Mergers and Acquisitions Analysis
9. COMPANY PROFILES
9.1. Hoffmann-La Roche AG*
9.1.1. Company Overview
9.1.2. Product Portfolio and Description
9.1.3. Financial Overview
9.1.4. Key Developments
9.2. Medtronic Plc
9.3. Abbott Laboratories
9.4. Novo Nordisk A/S
9.5. DexCom, Inc.
9.6. Nipro Medical
9.7. Sol-Millennium Medical Group
9.8. SABIC
9.9. Colexa Biosensor Ltd.
9.10. AMETEK.Inc. (*LIST NOT EXHAUSTIVE)
10. APPENDIX
10.1. About Us and Services
10.2. Contact Us
